TMCI ▲ +2.6% - Treace Medical Concepts, Inc. $TMCI - Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure Treace Medical Concepts rose 2.6% after announcing positive results from three clinical studies, including five-year data from the ALIGN3D trial showing sustained positive outcomes for its Lapiplasty® procedure. The long-term efficacy data appears to have reinforced investor confidence in the company's flagship bunion correction technology. 17-SEP-2026 05:16 PM ET